Eli Lilly reports first successful Phase 3 trial for oral GLP-1 medication
StreetAccount Summary: Stocks reaching new 52-week highs/lows (624 total)
StreetAccount Summary: Notable Drug Events expected for the week of 23-Mar
US experiencing interruptions in the supply of hemodialysis bloodlines - FDA
Powered by FactSet Research Systems Inc.